EUVIMEDEUVIMED entdecken
Open Access

Cardiac Biomarkers in Pregnancies With and Without Hypertension

Lara C Kovell iD, Mawulorm K I Denu, Julia Berkowitz, Sravya Shankara, Cassie Shao, Ekaterina Skaritanov, Gianna Wilkie, Tiffany A Moore Simas, Stephen P Juraschek iD

American Journal of Hypertension · 2025

DOI: 10.1093/ajh/hpaf061 ↗

Kurz gefasst

Fachartikel in der Zeitschrift American Journal of Hypertension, 2025. Verfasst von Lara C Kovell und 8 weiteren Autor:innen. Beteiligte Einrichtung: Division of Cardiovascular Medicine, Department of Medicine, UMass Chan Medical School, Worcester, Massachusetts, USA. Hauptthemen laut MEDLINE: Natriuretic Peptide, Brain, Peptide Fragments, Troponin I, Hypertension, Pregnancy-Induced. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NHLBI NIH HHS, National Heart, Lung, and Blood Institute.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Mechanisms of injury due to hypertension (HTN) in pregnancy remain poorly characterized. This study examined trends in markers of cardiac injury (high-sensitivity troponin I, hs-cTnI), strain (N-terminal pro–B-type natriuretic peptide, NT-proBNP), and inflammation (high-sensitivity C-reactive protein, hs-CRP) in pregnancies with and without HTN.

Methods

This prospective, 1:1 case-control study enrolled pregnant women with and without HTN (24–32 weeks gestation) from 2019 to 2022. HTN was defined by a clinical diagnosis of HTN or baseline blood pressure (BP) ≥ 140/90 mm Hg. Serum was collected at baseline, predelivery, and postpartum day 1. Mixed effects tobit models compared log-transformed hs-cTnI, NT-proBNP, and hs-CRP across HTN groups and over time, adjusted for age and body mass index.

Results

Mean baseline BP was 130.5 (17.5)/88.2 (13.5) mm Hg for the HTN group (n = 38, 86.8% chronic, 13.2% gestational HTN), and 112.0 (9.8)/70.9 (8.2) mm Hg for those without HTN (n = 38). Over pregnancy, the HTN group had higher hs-cTnI than those without HTN (2.12 [0.43] vs. 1.07 [0.25], Δ1.05 [95%CI: 0.07–2.03] ng/l). Compared to baseline, hs-cTnI increased at predelivery and postpartum for both groups. Overall, the two groups had similar NT-proBNP (HTN: 39.0 [4.5] vs. no HTN: 35.6 [4.3] pg/mL) and hs-CRP (HTN: 12.0 [1.7] vs. no HTN: 9.9 [1.5] mg/L). For both groups, NT-proBNP and hs-CRP increased from baseline to postpartum (NT-proBNP, HTN: 127% [58–227%], no HTN: 120% [51–219%]; hs-CRP: HTN: 550% [343–853%], no HTN: 664% [415–1,034%]).

Conclusion

HTN was associated with markers of cardiac injury during pregnancy, while delivery alone led to increases in markers of strain and inflammation. These biomarker changes associated with HTN in pregnancy may represent potential mechanisms to explain adverse cardiovascular events.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Natriuretic Peptide, BrainPeptide FragmentsTroponin IHypertension, Pregnancy-InducedHypertensionHumansFemalePregnancyBiomarkersAdultCase-Control StudiesProspective StudiesC-Reactive ProteinBlood Pressure

Stichwörter der Autor:innen

N-terminal pro–B-type natriuretic peptideblood pressurecardiovascular diseasehigh-sensitivity C-reactive proteinhigh-sensitivity cardiac troponin Ihypertensionpregnancy

Substanzen

BiomarkersNatriuretic Peptide, BrainPeptide Fragmentspro-brain natriuretic peptide (1-76)Troponin IC-Reactive Protein

Autor:innen und Institutionen

  • Division of Cardiovascular Medicine, Department of Medicine, UMass Chan Medical School, Worcester, Massachusetts, USA.
  • Department of Obstetrics and Gynecology, UMass Chan Medical School/UMass Memorial Health, Worcester, Massachusetts, USA.
  • Department of Internal Medicine, Tufts Medical Center, Boston, Massachusetts, USA.
  • Departments of Internal Medicine and Pediatrics, Warren Alpert Medical School at Brown University, Providence, Rhode Island, USA.
  • Departments of Pediatrics, Population and Quantitative Health Sciences, and Psychiatry, UMass Chan Medical School, Worcester, Massachusetts, USA.
  • Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts, USA.

ORCID-Profile: Lara C Kovell, Stephen P Juraschek

Förderung

  • NHLBI NIH HHS
  • National Heart, Lung, and Blood Institute

Zitieren

APA

Kovell, L. C., Denu, M. K. I., Berkowitz, J., Shankara, S., Shao, C., Skaritanov, E., Wilkie, G., Simas, T. A. M., & Juraschek, S. P. (2025). Cardiac Biomarkers in Pregnancies With and Without Hypertension. American Journal of Hypertension. https://doi.org/10.1093/ajh/hpaf061

Vancouver

Kovell LC, Denu MKI, Berkowitz J, Shankara S, Shao C, Skaritanov E, et al. Cardiac Biomarkers in Pregnancies With and Without Hypertension. American Journal of Hypertension. 2025. doi:10.1093/ajh/hpaf061

BibTeX
@article{Kovell2025,
  author = {Kovell, Lara C and Denu, Mawulorm K I and Berkowitz, Julia and Shankara, Sravya and Shao, Cassie and Skaritanov, Ekaterina and Wilkie, Gianna and Simas, Tiffany A Moore and Juraschek, Stephen P},
  title = {Cardiac Biomarkers in Pregnancies With and Without Hypertension},
  journal = {American Journal of Hypertension},
  year = {2025},
  doi = {10.1093/ajh/hpaf061}
}
Kostenlos starten →